Stay updated on Cenicriviroc Rollover Study in NASH Liver Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Cenicriviroc Rollover Study in NASH Liver Fibrosis Clinical Trial page.

Latest updates to the Cenicriviroc Rollover Study in NASH Liver Fibrosis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision history shows a new UI version (v3.4.2) and removal of the prior version (v3.4.1). This is a minor interface update that does not affect study data or functionality.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed from the history.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded a glossary option and color-coded highlights to distinguish additions and deletions (green for additions, red for deletions). Updated the revision to v3.4.0 and adjusted the No FEAR Act data labeling.SummaryDifference0.9%

- Check38 days agoChange DetectedThe Record History/Study Record Versions sections and the version list controls have been removed, so past study versions and their changes are no longer visible.SummaryDifference10%

- Check45 days agoChange DetectedThe Record History shows a new revision entry (v3.3.4) and removal of the previous revision (v3.3.3). This is a minor metadata update that does not affect trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedA new Revision: v3.3.3 appears and the HHS Vulnerability Disclosure footer link and Revision: v3.3.2 were removed; these are minor site-wide edits and do not alter the trial record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Cenicriviroc Rollover Study in NASH Liver Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cenicriviroc Rollover Study in NASH Liver Fibrosis Clinical Trial page.